Literature DB >> 26829660

Isolated Hepatitis B Core Antibody is Associated With Advanced Hepatic Fibrosis in HIV/HCV Infection But Not in HIV Infection Alone.

Debika Bhattacharya1, Chi-Hong Tseng, Janet P Tate, Vincent Lo Re, Cynthia L Gibert, Adeel A Butt, Sheldon T Brown, Joseph K Lim, Maria C Rodriguez-Barradas, David Rimland, Erica Kaufman, Amy C Justice, Matthew Bidwell Goetz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26829660      PMCID： PMC4837046          DOI： 10.1097/QAI.0000000000000941

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN： 1525-4135            Impact factor:   3.731


× No keyword cloud information.
  17 in total

Review 1.  Microbial infections, immunomodulation, and drugs of abuse.

Authors:  Herman Friedman; Catherine Newton; Thomas W Klein
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

2.  Prevalence, risk factors, and outcomes for occult hepatitis B virus infection among HIV-infected patients.

Authors:  Vincent Lo Re; Ian Frank; Robert Gross; Janel Dockter; Jeffrey M Linnen; Cristina Giachetti; Pablo Tebas; John Stern; Marie Synnestvedt; A Russell Localio; Jay R Kostman; Brian L Strom
Journal:  J Acquir Immune Defic Syndr       Date:  2007-03-01       Impact factor: 3.731

3.  Development and verification of a "virtual" cohort using the National VA Health Information System.

Authors:  Shawn L Fultz; Melissa Skanderson; Larry A Mole; Neel Gandhi; Kendall Bryant; Stephen Crystal; Amy C Justice
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

4.  Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.

Authors:  Judith I Tsui; Audrey L French; Eric C Seaberg; Michael Augenbraun; Marek Nowicki; Marion Peters; Phyllis C Tien
Journal:  Clin Infect Dis       Date:  2007-08-10       Impact factor: 9.079

5.  Occult hepatitis B virus infection in the setting of hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection: clinically relevant or a diagnostic problem?

Authors:  M Rodríguez-Torres; J Gonzalez-Garcia; N Bräu; R Solá; S Moreno; J Rockstroh; F Smaill; M C Mendes-Correa; J DePamphilis; F J Torriani
Journal:  J Med Virol       Date:  2007-06       Impact factor: 2.327

6.  A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.

Authors:  Chun-Tao Wai; Joel K Greenson; Robert J Fontana; John D Kalbfleisch; Jorge A Marrero; Hari S Conjeevaram; Anna S-F Lok
Journal:  Hepatology       Date:  2003-08       Impact factor: 17.425

7.  Incidence of transaminitis among HIV-infected patients with occult hepatitis B.

Authors:  Vincent Lo Re; Benjamin Wertheimer; A Russell Localio; Jay R Kostman; Janel Dockter; Jeffrey M Linnen; Cristina Giachetti; Zachariah Dorey-Stein; Ian Frank; Brian L Strom; Robert Gross
Journal:  J Clin Virol       Date:  2008-05-16       Impact factor: 3.168

8.  Hepatitis B virus and HIV coinfection: relationship of different serological patterns to survival and liver disease.

Authors:  M K Osborn; J L Guest; D Rimland
Journal:  HIV Med       Date:  2007-07       Impact factor: 3.180

9.  Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.

Authors:  Vincent Lo Re; Michael J Kallan; Janet P Tate; A Russell Localio; Joseph K Lim; Matthew Bidwell Goetz; Marina B Klein; David Rimland; Maria C Rodriguez-Barradas; Adeel A Butt; Cynthia L Gibert; Sheldon T Brown; Lesley Park; Robert Dubrow; K Rajender Reddy; Jay R Kostman; Brian L Strom; Amy C Justice
Journal:  Ann Intern Med       Date:  2014-03-18       Impact factor: 25.391

10.  Very low prevalence and no clinical significance of occult hepatitis B in a cohort of HIV-infected patients with isolated anti-HBc seropositivity: the BHOI study.

Authors:  R Palacios; R Mata; A Hidalgo; L Muñoz; I Viciana; A Del Arco; L F López-Cortés; A Peña; J de la Torre; J Santos
Journal:  HIV Clin Trials       Date:  2008 Sep-Oct
View more
  6 in total

Review 1.  Significance and Management of Isolated Hepatitis B Core Antibody (Anti-HBc) in HIV and HCV: Strategies in the DAA Era.

Authors:  Jennifer J Chang; Neaka Mohtashemi; Debika Bhattacharya
Journal:  Curr HIV/AIDS Rep       Date:  2018-04       Impact factor: 5.071

Review 2.  Update in HIV-hepatitis C virus coinfection in the direct acting antiviral era.

Authors:  Eric G Meissner
Journal:  Curr Opin Gastroenterol       Date:  2017-05       Impact factor: 3.287

3.  Chronic Hepatitis B in US Veterans.

Authors:  Patrik Garren; Marina Serper
Journal:  Curr Hepatol Rep       Date:  2019-07-29

4.  HBcAb Positivity Increases the Risk of Severe Hepatic Fibrosis Development in HIV/HCV-Positive Subjects From the ICONA Italian Cohort of HIV-Infected Patients.

Authors:  Vincenzo Malagnino; Carlotta Cerva; Antonella Cingolani; Francesca Ceccherini-Silberstein; Alessandra Vergori; Gianluca Cuomo; Carlo Federico Perno; Massimo Puoti; Antonella d'Arminio Monforte; Alessandro Cozzi-Lepri; Massimo Andreoni; Loredana Sarmati
Journal:  Open Forum Infect Dis       Date:  2020-11-18       Impact factor: 3.835

Review 5.  Isolated Anti-HBc: Significance and Management.

Authors:  Florian Moretto; François-Xavier Catherine; Clémentine Esteve; Mathieu Blot; Lionel Piroth
Journal:  J Clin Med       Date:  2020-01-11       Impact factor: 4.241

6.  Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection.

Authors:  Barbara Rossetti; Valentina Borgo; Arianna Emiliozzi; Marta Colaneri; Giacomo Zanelli; Miriana d'Alessandro; Davide Motta; Laura Maiocchi; Francesca Montagnani; Maria Cristina Moioli; Chiara Baiguera; Margherita Sambo; Teresa Chiara Pieri; Pietro Valsecchi; Raffaele Bruno; Massimo Puoti; Massimiliano Fabbiani
Journal:  Diagnostics (Basel)       Date:  2021-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.